Stony Brook University

Running trials

• Recruiting

  Controlled Trial of Hydrogen Water as a Treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  NCT07753122· Fred Friedberg· Source

• Recruiting

  Behavioral Activation for Treatment of Depression in Autistic Adolescents With Below Average Intelligence

  NCT07812870· Stony Brook University· Source

• Recruiting

  A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  NCT07330258· Bayer· Source

• Recruiting

  Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

  NCT07040319· Phase 1/2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Recruiting

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  NCT07415044· Phase 2· Eli Lilly and Company· Source

• Recruiting

  The Role of mGluR5 in CBT-I

  NCT07076342· Phase 4· Stony Brook University· Source

• Recruiting

  Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)

  NCT06693011· Cerus Endovascular, Inc.· Source

• Recruiting

  Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS

  NCT07009691· Stony Brook University· Source

• Active, not recruiting

  Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

  NCT06760637· Phase 3· Pfizer· Source

• Recruiting

  Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors

  NCT07215091· Stony Brook University· Source

• Active, not recruiting

  First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

  NCT06239467· Phase 1· OnKure, Inc.· Source

• Active, not recruiting

  A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

  NCT06111235· Phase 3· CG Oncology, Inc.· Source

• Recruiting

  A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT05730036· Phase 3· Regeneron Pharmaceuticals· Source

• Recruiting

  The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  NCT05836987· Phase 3· Johns Hopkins University· Source

• Active, not recruiting

  MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study

  NCT05409989· Microvention-Terumo, Inc.· Source

• Recruiting

  Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

  NCT04839705· Microvention-Terumo, Inc.· Source

• Active, not recruiting

  A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

  NCT05269004· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

  NCT04977024· Phase 2· GeoVax, Inc.· Source

• Active, not recruiting

  Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

  NCT04452591· Phase 3· CG Oncology, Inc.· Source

• Active, not recruiting

  TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

  NCT04485013· Phase 1· Tizona Therapeutics, Inc· Source

• Active, not recruiting

  A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma

  NCT04268498· Phase 2· University of Miami· Source

• Recruiting

  Stroke Thrombectomy and Aneurysm Registry

  NCT04994756· Medical University of South Carolina· Source

• Active, not recruiting

  Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

  NCT03765918· Phase 3· Merck Sharp & Dohme LLC· Source

• Active, not recruiting

  Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia

  NCT02665065· Phase 3· Actinium Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Brain aneurysm3 recruiting
• Long COVID and ME/CFS2 recruiting
• Stroke2 recruiting
• Atrial fibrillation1 recruiting
• Autism1 recruiting
• Childhood cancers1 recruiting
• Depression1 recruiting
• Hepatitis C1 recruiting
• HIV1 recruiting
• Insomnia1 recruiting
• Parkinson disease1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.

  NCT07095205· Phase 4· Stony Brook University· Source

• Withdrawn

  A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

  NCT06205290· Phase 3· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Terminated

  Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia

  NCT05724810· Stony Brook University· Source

• Completed

  Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

  NCT05634811· Phase 3· Pfizer· Source

• Completed

  Abbott i-STAT High Sensitivity Troponin I Study

  NCT05629572· Abbott Point of Care· Source

• Completed

  Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

  NCT05152524· Rapid Medical· Source

• Terminated

  Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer

  NCT04958785· Phase 2· Gilead Sciences· Source

• Terminated

  Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

  NCT04795466· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

  NCT04847557· Phase 3· Eli Lilly and Company· Source

• Completed

  A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia

  NCT04457310· Phase 2· Yale University· Source

• Completed

  Rostock International Parkinson's Disease Study (ROPAD)

  NCT03866603· CENTOGENE GmbH Rostock· Source

• Completed

  Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

  NCT03941093· Phase 3· Kyntra Bio· Source

• Completed

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· Phase 3· Stemline Therapeutics, Inc.· Source

• Completed

  A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms

  NCT03642639· Cerenovus, Part of DePuy Synthes Products, Inc.· Source

• Completed

  MIND: Artemis in the Removal of Intracerebral Hemorrhage

  NCT03342664· Penumbra Inc.· Source

• Completed

  Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

  NCT03279185· Harvard School of Public Health (HSPH)· Source

• Completed

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· Phase 3· Pfizer· Source

• Completed

  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

  NCT02089217· Mayo Clinic· Source

• Completed

  Framing Eighteen Coils in Cerebral Aneurysms Trial

  NCT01655784· Vanderbilt University Medical Center· Source

• Completed

  A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

  NCT00676715· Phase 2· Genentech, Inc.· Source

• Completed

  Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

  NCT01310023· Harvard School of Public Health (HSPH)· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Long COVID and ME/CFS11 works · 2 trials
• Lyme disease8 works · 1 trial
• Hidradenitis suppurativa8 works · 0 trials
• Brain aneurysm7 works · 6 trials
• Alopecia areata6 works · 0 trials